BRIEF-Shilpa Medicare Gets 483 Observations From U.S. FDA For SEZ Formulation Facilities In Telangana

Dec 5 (Reuters) – Shilpa Medicare Ltd:
* SAYS GOT 483 OBSERVATIONS …
Go to Source